Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Cardiomyocyte cytosolic nuclear self-DNA contributes to the pathogenesis of desmoplakin cardiomyopathy
Weiyue Wang, Benjamin Cathcart, Quoc D. Nguyen, Loi Q. Lao, Amelia Bryans, Sara E. Coleman, Leila Rouhi, Priyatansh Gurha, Ali J. Marian
Weiyue Wang, Benjamin Cathcart, Quoc D. Nguyen, Loi Q. Lao, Amelia Bryans, Sara E. Coleman, Leila Rouhi, Priyatansh Gurha, Ali J. Marian
View: Text | PDF
Research Article Cardiology Genetics

Cardiomyocyte cytosolic nuclear self-DNA contributes to the pathogenesis of desmoplakin cardiomyopathy

  • Text
  • PDF
Abstract

Hereditary cardiomyopathies are the prototypic forms of heart failure and major causes of sudden cardiac death. The genome in cardiomyopathies is exposed to internal stressors, which damage the DNA and activate the DNA damage response (DDR) pathways. We set out to determine whether the DDR pathways were activated and pathogenic in an established mouse model of desmoplakin (DSP) cardiomyopathy generated upon deletion of the Dsp gene in cardiomyocytes (Myh6-MerCreMerTam Dspfl/fl; Myh6-McmTam Dspfl/fl). The mice exhibited premature death, cardiac dysfunction, myocardial cell death, fibrosis, and increased expression levels of the pro-inflammatory cytokines, consistent with the phenotype of human DSP cardiomyopathy. Cytosolic nuclear self-DNA (nDNA) and mitochondrial DNA (mtDNA) were increased in cardiomyocyte cytosol in the Myh6-McmTam Dspfl/fl mice. Likewise, the DDR pathway proteins, including the cyclic GMP-AMP synthase (CGAS)/stimulator of interferon response 1, were upregulated, as were the transcript levels of interferon response factor 3 and the NF-κB target genes. Deletion of the Mb21d1 gene encoding CGAS in the Myh6-McmTam Dspfl/fl mice prolonged survival, improved cardiac function, attenuated fibrosis, and reduced cell death. Thus, cytosolic nDNA and mtDNA are increased and the DDR pathways are activated and pathogenic in a mouse model of DSP cardiomyopathy, whereas genetic blockade of CGAS is salubrious.

Authors

Weiyue Wang, Benjamin Cathcart, Quoc D. Nguyen, Loi Q. Lao, Amelia Bryans, Sara E. Coleman, Leila Rouhi, Priyatansh Gurha, Ali J. Marian

×

Figure 7

Effects of deletion of Mb21d1 gene on survival, cardiac function, and expression of heart failure biomarkers.

Options: View larger image (or click on image) Download as PowerPoint
Effects of deletion of Mb21d1 gene on survival, cardiac function, and ex...
(A) Kaplan-Meier survival plots in mice in 5 control and experimental groups. Each data point identifies 1 mouse alive at that time point, and each vertical drop indicates a death (N = 21 to 40 per genotype). The survival rates were compared by the log-rank test. (B) Dot plots showing heart weight/body weight ratio in the experimental groups (N = 17 to 21 mice per group). The P values were calculated by ANOVA and pairwise comparisons by the Bonferroni method. Only P values < 0.05 are depicted. (C) Selected echocardiographic indices of cardiac size and function are shown as dot plots in the 5 groups. Data on left ventricular end-diastolic diameter (LVEDD), LV end-systolic diameter (LVESD), LV fractional shortening (LVFS), and LV ejection fraction (LVEF) are depicted. The differences were compared by ANOVA followed by pairwise comparison by the Bonferroni method. Only P values < 0.05 are shown (N = 10 to 15 per genotype). (D) Dot plots showing cardiomyocyte transcript levels of a dozen selected genes that are the targets of IRF3 or NF-κB1 and are considered biomarkers for heart failure. Data are normalized to Vcl levels and shown as a fold change to that in the WT mice. (E) Immunoblots showing expression levels of selected proteins in the control and experimental groups (N = 6 per group). (F) Quantitative dot blot data representing the blot shown in E. The data are normalized to the VCL levels and shown as fold change. The differences among the groups are compared by Welch’s ANOVA followed by pairwise comparison by Dunnett’s T3 multiple comparisons. Only significant P values are shown. Each dot represents 1 independent sample (N = 6 per genotype).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts